Acadian Asset Management LLC Xenon Pharmaceuticals Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$14.86 - $19.45 $35,143 - $45,999	-2,365 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$16.81 - $20.0 $408,281 - $485,760	-24,288 Reduced 91.13%	2,365 $44,000
Q1 2021 May 11, 2021	SELL	$13.65 - $21.31 $692,123 - $1.08 Million	-50,705 Reduced 65.55%	26,653 $476,000
Q4 2020 Feb 11, 2021	SELL	$9.49 - $16.04 $50,856 - $85,958	-5,359 Reduced 6.48%	77,358 $1.19 Million
Q3 2020 Nov 09, 2020	BUY	$10.82 - $13.35 $235,756 - $290,883	21,789 Added 35.76%	82,717 $915,000
Q2 2020 Aug 12, 2020	BUY	$10.21 - $14.9 $564,041 - $823,135	55,244 Added 971.92%	60,928 $762,000
Q1 2020 May 11, 2020	BUY	$8.08 - $17.57 $45,926 - $99,867	5,684 New	5,684 $64,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.